Background: The wide and indiscriminate use of drugs has increased the incidence and the modes of presentation of cutaneous drug reaction. Adverse cutaneous drug reactions are common, comprehensive information about their incidence, severity and ultimate health effects are unavailable.
INTRODUCTION
According to WHO, Pharmacovigilance is "The Pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side effects of medicines." [1] An Adverse Cutaneous Drug Reaction (ACDR) caused by a drug is any undesirable change in the structure or function of the skin, its appendages or mucous membranes and it encompasses all adverse events related to drug eruption, regardless of the etiology. [2] Drug eruptions are among the most common cutaneous disorders encountered by the dermatologist. [3, 4] There is a wide spectrum of ACDRs varying from transient maculopapular rash to fatal toxic epidermal necrolysis (TEN) [5] and acneform eruption [6] . Mode of onset, severity and underlying mechanism varies for different types of ACDRs. The wide and indiscriminate use of drugs has increased the incidence and the modes of presentation of cutaneous drug reaction. [7] The incidence of ACDRs in developed countries range from 1 to 3% among indoor patients, [8] [9] [10] whereas in developing countries such as India, some studies have documented it to 2 to 5% of the indoor patients; [11] [12] [13] [14] however, there is lack of comprehensive data regarding out-patient department. The inadequacy of data could be attributed to lack of awareness to report Adverse Drug Reaction (ADR). ADR reporting directly helps to drug monitoring and may even guide to Pharmaceutical companies and regulatory authorities for better drug usage. The pattern of cutaneous adverse drug eruptions and the drugs responsible for them keep changing every year. [11] Although such cutaneous reactions are common, comprehensive information about their incidence, severity and ultimate health effects are unavailable. [15] So this study was undertaken to evaluate incidence and causality of ACDRs in dermatology department of our tertiary care centre and to compare it with hospital data to assess the impact of Pharmacovigilance on ADR reporting. On the basis of collected data, incidence rate was calculated and the ACDRs were classified on the basis of age, sex and most common drug causing them. Causality assessment was done by WHO causality assessment scale [17] , classifying ADR in to certain, probable, possible, unlikely, unclassified and unassessible. ACDRs reported under certain, probable and possible were included in study. Severity assessment was done by modified Hartwig and Siegel's scale [18] , which classifies severity of ADR as mild, moderate or severe based on factors like necessity of change in treatment, increased duration of hospital stay and disability produced by ADR. Assessment of preventability was done by modified Schomock and Thronton scale. [19] According to this scale detected ACDRs were categorised in to definitely preventable, probably preventable and not preventable.
MATERIALS AND METHODS
Simultaneously retrospective study of patients attended Dermatology OPD over last 4 years was carried out from the available data in register of Dermatology department. Patients diagnosed as ACDRs were noted and incidence rate was calculated. Data was classified for most common reaction and most common drugs or drug group causing it. Confidentiality of the patient data was maintained throughout the study.
Statistical Analysis
Results from both the studies were compared for association by chi-square test using MedCalc. Software version 7.6.0.0 (p <0.05 was considered as significant).
RESULTS
In prospective study 29,156 patients attending dermatology OPD were observed. Out of all observed patients 48 (0.17%) were diagnosed as having ACDRs by dermatologists. Most cases had reaction time between 1 to 10 days. The most common age group diagnosed as having ACDRs was 18-35 years and higher incidence rate was observed in male as compared to females (M:F = 1:0.66) [ Table 1 ]. The most common drugs responsible for ACDRs in prospective study were betamethasone, isoniazid and rifampicin for acneform eruption, while metronidazole and paracetamol for FDE. 
Figure-3: Steven Johnson Syndrome
In retrospective study according to hospital data 61,000 patient attended Dermatology OPD during above duration. Out of 61000 63 (0.10%) patients were documented as having ACDRs by Dermatologists. Most common was FDE (28.57%) followed by Acneform eruption (11.11%). Other documented ACDRs were SJ syndrome [ Figure-3] , melasma, angioedema, erythema multiformae, urticaria, drug induced erythroderma, maculopapular exanthema, pellagrous dermatitis, hypertrichosis, stria, hyperpigmentation, bullous FDE and phototoxic reaction in descending order.
The most common drug groups responsible were antimalarial and fluroquinolones for FDE [ Figure-4 ], while acneform eruption was mainly caused by systemic steroids. Drug groups responsible for other ACDRs were antituberculer, antipsychotics, antibiotics and NSAIDs [ Table-5 ].
Figure-4: Fixed Drug Eruption
Comparison between Prospective and retrospective study was carried out by chisquare test. Analysis showed that comparison was significant (x 2 =6.03) (p< 0.05). It suggests that there was significant association between prospective study and retrospective study with higher incidence rate of ACDRs in prospective study.
DISCUSSION
This study was carried out with an approach to reveal pattern of ACDRs with simultaneous vision of establishing impact of Pharmacovigilance activity in our tertiary care centre. The ACDRs reported was 0.17% of the observed patients in prospective study analysis, while in retrospective study analysis it was documented in 0.10% of the observed patients. In a study conducted by chatterjee at el. [15] (2006) the incidence of drug induced adverse skin reaction was found to be 2 to 6 % at dermatology out patient setting. The fewer incidences in our study might be due to better drug prescribing method or still lack of awareness regarding ADR reporting, but incidence rate in prospective study was higher as compared to retrospective study data. There was significant association between both the studies suggesting impact of Pharmacovigilance on reporting of ACDRs.
Pudukadan D et al. [11] (2004) revealed that most common age group was 20-39 years followed by 40-59 years with higher incidence in female (M:F = 0.87:1), similarly in our study most common age group was 18-35 years followed by 36-62 years, but with male preponderance (M:F = 1:0.66), However other studies have been reported with high male female ratio. [3, 5] A broad clinical spectrum of ACDRs was observed in this study. FDE (28.57% & 22.92%) and acneform eruption (25% & 11.11%) were the most common ACDRs in prospective study and retrospective study. Others have noted maculopapular rash and FDE as the most common ACDRs. [5, 6, 15] Analysis of results showed that in prospective study metronidazole and paracetamol, while in retrospective study antimalarial and fluroquinolones were the most common drugs responsible for FDE, which has already been reported. [4] Other studies [5, 9] have documented sulfonamides and tetracycline as the most common causative agent.
In consonance with earlier study [6] steroids and anti-tuberculer drugs were responsible for acneform eruption in this study. Causative agents for SJ syndrome in this study were antipsychotics, which is supported by other studies. [5, 12, 15] Other causative agents for ACDRs revealed by this study were antimicrobials (22.92%), steroids (18.75%) and NSAIDs (10.42%), which is in concordance to results of other studies. [5, 15] Causality assessment revealed 27.08% were certain, 50% were probable and 22.92% were possible which was comparable to Chatterjee et al. [15] (2006) . As supported by literature [2] Hartwig severity assessment showed 2% of total reported ACDRs were severe. Importantly, in this study preventability assessment was done by modified Schomock and Thronton scale which was lacking in other studies done on ACDRs. In retrospective study causality, severity and preventability assessment was not possible due to lack of sufficient data. This shows importance of Pharmacovigilance activity in proper assessment of ADR. Interesting part of this study was detection of some rare ACDRs such as pellagrous dermatitis and hypertrichosis. Our hospital is situated in Surendranagar district of Gujarat, which has flow of patients who belongs to poor socioeconomic class, so major limitation of this study was that it could not reveal pattern of ACDRs in higher socioeconomic class. This study can be further carried out on wide basis for better evaluation of ACDRs.
CONCLUSION
Fixed drug eruption and acneform eruption are the most commonly encountered ACDRs at our tertiary care centre. Most common drugs responsible were corticosteroids, isoniazid, rifampicin, metronidazole, fluroquinolone and antimalarial drugs. Pharmacovigilance activity is significantly effective in increasing the reporting of ADRs.
